The inhibition of Wnt/β-catenin signaling by BRAF activation in melanoma cells was not observed in normal melanocytes, consistent with a model in which MAPK-mediated disruption of homeostatic Wnt/β-catenin signaling can contribute to melanoma progression. This evidence concerns the gene BRAF and melanoma.